Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
WO 2021053040
MÉTHODES DE RADIOMARQUAGE D'ANTAGONISTES DE GRPR ET LEURS KITS
granted -
WO 2021052960
COMPOSITION RADIOPHARMACEUTIQUE CONCENTRÉE, STABLE
granted -
US 10953209
Treating tumors using TTFields combined with a PARP inhibitor
granted -
US 10954529
Minimal volume reprogramming of mononuclear cells
granted -
US 10954498
Modified cascade ribonucleoproteins and uses thereof
granted -
US 10954259
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
granted -
US 10954198
Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases
granted -
US 10953047
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 10953040
Methods of treating bacterial infections with penam β-lactam antibiotics and branched poly(ethylenimine)
granted -
US 10952996
ALK5 inhibitors
granted -
US 10953026
N-acetyl mannosammine as a therapeutic agent
granted -
US 10952978
Hepatitis B antiviral agents
granted -
US 10953110
Dual emissive metal nanoparticles as ratiometric pH indicators
granted -
US 10954530
Retroviral and lentiviral vectors
granted -
US 10954516
GNAQ targeted dsRNA compositions and methods for inhibiting expression
granted -
US 10954501
Nucleic acid encoding modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use
granted -
US 10954492
Processes for production and purification of nucleic acid-containing compositions
granted -
US 10954304
Neutralizing antibodies to the αvβ8 integrin complex for immunotherapy
granted -
US 10954295
Correctly folded etanercept in high purity and excellent yield
granted -
US 10954294
Correctly folded etanercept in high purity and excellent yield
granted -
US 10954291
Monoclonal antibodies that specifically bind to matrilin-3 and their use
granted -
US 10954289
Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments
granted -
US 10954293
Correctly folded etanercept in high purity and excellent yield
granted -
US 10954287
Ras binding peptides and methods of use
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.